Dr.Jart+

Dr.Jart+ is a South Korean skincare brand from Seoul, known chiefly for helping popularise BB cream as a cosmetic and for derma-style products such as the Cicapair and Ceramidin lines. Since 2019 it has been owned by The Estée Lauder Companies, which acquired the brand in full [5]; it continues to operate as a sub-brand within that group rather than as an independent company.

The company describes its name as standing for "doctor joins art" — a philosophy, in its own framing, rather than an actual doctor — combining skincare ingredients and innovation with what it calls artful, high-performance products [1].

According to the brand's own account, Dr.Jart+ was founded in Seoul in 2005 by Leeo (Chin Wook) Lee, who was working as an architect when he encountered a makeup-like blemish balm sold only in dermatology clinics. Drawn to its hybrid function, he worked with labs to combine skincare benefits with foundation coverage, and the resulting BB Cream became a hit in Korea.

Sources differ on the founding date and the founder's name. The brand site dates the founding to 2005, which matches WWD's report that "ChinWook Lee founded the company in 2005" [5]; Wikipedia gives 2004, with research beginning in 2003 and a commercial BB-cream launch in December 2004 [2] — a difference that likely reflects the launch year versus the company's own founding date. On the name, Wikipedia describes "Jart" as a portmanteau of "Jung" and "art," referring to dermatologist Jung Sung-jae, who consulted on the brand; one editorial guide goes further and frames Jung as the establisher [4]. The brand's own materials instead present the founder as Lee and gloss the name as "doctor joins art" [1].

Dr.Jart+ is credited with pioneering the marketing of BB cream as a cosmetic, and the format is closely tied to the brand's early identity [2]. It entered the United States in 2011 through a partnership with Sephora, and refreshed its branding in 2018, around the time of the Ceramidin line. Marie Claire UK has described it as "the South Korean brand founded by an architect almost 20 years ago," built on a promise of high-performance skincare [3].

The brand's operating company is Have & Be Co., based in Seoul. The Estée Lauder Companies first took a minority stake in Have & Be Co. in 2015, then acquired full ownership in 2019, paying roughly $1.1 billion for the remaining two-thirds it did not already own, at an enterprise value of about $1.7 billion [5]. WWD reported it as the group's first acquisition of an Asia-based beauty brand, with Dr.Jart+ expected to drive sales of more than $500 million for 2019 after several years of rapid growth [5]. Within The Estée Lauder Companies, it sits alongside brands including Estée Lauder, La Mer, Clinique, Jo Malone London and M·A·C Cosmetics.

Dr.Jart+ positions itself as high-performance "derma" skincare with a playful tone. In its own words, it joins "skincare's best ingredients and innovations (that's the Dr.) … with artful experiences," and presents itself as a philosophy rather than a doctor [1]. It is sold through specialty channels, travel retail, freestanding stores, department stores and e-commerce.

Two collections anchor the range. Cicapair centres on Centella asiatica — also called tiger grass — an ingredient long associated with soothing irritated, red or blemished skin; its Tiger Grass colour-correcting treatment is among the brand's better-known products. Ceramidin is built around ceramides, using what the brand calls a 5-Cera Complex intended to restore moisture in dry skin [4]. Other lines include the Premium BB beauty balm and the Cryo Rubber masks.

Marie Claire UK, in a 2024 roundup by four beauty editors, described Dr.Jart+ as having "many 'cult' favourites and bestsellers," singling out the Ceramidin Cream as "a real contender for the top spot" and noting that the Cicapair treatment "absolutely delivers on its promise," though not for every skin type [3].

Dr.Jart+ remains an active, globally distributed brand operating under The Estée Lauder Companies following the 2019 acquisition. Continued launches indicate ongoing activity, including its arrival in the US Amazon Premium Beauty store in 2024 [7].